China Large Molecules Drug Substance CDMO Market (2025-2031) | Segments, Investment Trends, Strategy, Forecast, Growth, Companies, Drivers, Segmentation, Demand, Competition, Opportunities, Supply, Pricing Analysis, Size, Trends, Industry, Challenges, Value, Restraints, Revenue, Outlook, Strategic Insights, Consumer Insights, Share, Competitive, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Large Molecules Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F

3.3 China Large Molecules Drug Substance CDMO Market - Industry Life Cycle

3.4 China Large Molecules Drug Substance CDMO Market - Porter's Five Forces

3.5 China Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F

3.6 China Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F

3.7 China Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Stage, 2021 & 2031F

3.8 China Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F

3.9 China Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing demand for biologics and biosimilars

4.2.2 Increasing outsourcing by pharmaceutical companies to focus on core competencies

4.2.3 Favorable government policies supporting the biopharmaceutical industry in China

4.3 Market Restraints

4.3.1 High capital investment required for establishing large molecule drug substance manufacturing facilities

4.3.2 Stringent regulatory requirements for large molecule drug manufacturing

4.3.3 Limited expertise and experience in large molecule drug substance manufacturing in China

6.1 China Large Molecules Drug Substance CDMO Market, By Service Type

6.1.1 Overview and Analysis

6.1.2 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F

6.1.3 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021 - 2031F

6.1.4 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F

6.1.5 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Analytical Services, 2021 - 2031F

6.1.6 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Regulatory Support, 2021 - 2031F

6.1.7 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Packaging, 2021 - 2031F

6.2 China Large Molecules Drug Substance CDMO Market, By Molecule Type

6.2.1 Overview and Analysis

6.2.2 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F

6.2.3 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Recombinant Proteins, 2021 - 2031F

6.2.4 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Peptides, 2021 - 2031F

6.2.5 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Nucleic Acids, 2021 - 2031F

6.2.6 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Viral Vectors, 2021 - 2031F

6.3 China Large Molecules Drug Substance CDMO Market, By Stage

6.3.1 Overview and Analysis

6.3.2 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Preclinical, 2021 - 2031F

6.3.3 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021 - 2031F

6.3.4 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021 - 2031F

6.3.5 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Late-Stage, 2021 - 2031F

6.3.6 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Early-Stage, 2021 - 2031F

6.4 China Large Molecules Drug Substance CDMO Market, By Application

6.4.1 Overview and Analysis

6.4.2 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Oncology, 2021 - 2031F

6.4.3 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Immunology, 2021 - 2031F

6.4.4 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Neurology, 2021 - 2031F

6.4.5 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Rare Diseases, 2021 - 2031F

6.4.6 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F

6.5 China Large Molecules Drug Substance CDMO Market, By End User

6.5.1 Overview and Analysis

6.5.2 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F

6.5.3 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031F

6.5.4 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By Research Institutes, 2021 - 2031F

6.5.5 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By CROs, 2021 - 2031F

6.5.6 China Large Molecules Drug Substance CDMO Market Revenues & Volume, By CMOs, 2021 - 2031F

7.1 China Large Molecules Drug Substance CDMO Market Export to Major Countries

7.2 China Large Molecules Drug Substance CDMO Market Imports from Major Countries

8.1 Percentage increase in the number of biologics and biosimilars in development

8.2 Growth in the number of partnerships between pharmaceutical companies and CDMOs in China

8.3 Number of new large molecule drug substance manufacturing facilities established in China

8.4 Increase in the number of skilled professionals trained in large molecule drug manufacturing technologies

8.5 Improvement in regulatory compliance and approvals for large molecule drug substances in China

9.1 China Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F

9.2 China Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Molecule Type, 2021 & 2031F

9.3 China Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Stage, 2021 & 2031F

9.4 China Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Application, 2021 & 2031F

9.5 China Large Molecules Drug Substance CDMO Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 China Large Molecules Drug Substance CDMO Market Revenue Share, By Companies, 2024

10.2 China Large Molecules Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters